IL144641A0 - Phenylalaninol derivatives - Google Patents

Phenylalaninol derivatives

Info

Publication number
IL144641A0
IL144641A0 IL14464100A IL14464100A IL144641A0 IL 144641 A0 IL144641 A0 IL 144641A0 IL 14464100 A IL14464100 A IL 14464100A IL 14464100 A IL14464100 A IL 14464100A IL 144641 A0 IL144641 A0 IL 144641A0
Authority
IL
Israel
Prior art keywords
alkyl
lower alkyl
alkanoyl
aryl
halo
Prior art date
Application number
IL14464100A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL144641A0 publication Critical patent/IL144641A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/80Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
IL14464100A 1999-02-18 2000-02-12 Phenylalaninol derivatives IL144641A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12049899P 1999-02-18 1999-02-18
PCT/EP2000/001168 WO2000048988A1 (en) 1999-02-18 2000-02-12 Phenylalaninol derivatives

Publications (1)

Publication Number Publication Date
IL144641A0 true IL144641A0 (en) 2002-05-23

Family

ID=22390691

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14464100A IL144641A0 (en) 1999-02-18 2000-02-12 Phenylalaninol derivatives
IL144641A IL144641A (en) 1999-02-18 2001-07-30 Phenylalanine derivatives, medicinal preparations containing them, methods of preparation and uses of phenylalanine derivatives in the preparation of drugs

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL144641A IL144641A (en) 1999-02-18 2001-07-30 Phenylalanine derivatives, medicinal preparations containing them, methods of preparation and uses of phenylalanine derivatives in the preparation of drugs

Country Status (29)

Country Link
US (1) US6420600B1 (no)
EP (1) EP1154987B1 (no)
JP (1) JP2002537283A (no)
KR (1) KR100636458B1 (no)
CN (1) CN1213020C (no)
AT (1) ATE264835T1 (no)
AU (1) AU771938B2 (no)
BR (1) BR0008368A (no)
CA (1) CA2362833C (no)
CZ (1) CZ20012984A3 (no)
DE (1) DE60010049T2 (no)
DK (1) DK1154987T3 (no)
ES (1) ES2218116T3 (no)
HK (1) HK1043589A1 (no)
HR (1) HRP20010594B1 (no)
HU (1) HUP0200343A3 (no)
ID (1) ID30057A (no)
IL (2) IL144641A0 (no)
MA (1) MA26772A1 (no)
MX (1) MXPA01008178A (no)
NO (1) NO20013946D0 (no)
PL (1) PL349463A1 (no)
PT (1) PT1154987E (no)
RU (1) RU2238265C2 (no)
SI (1) SI1154987T1 (no)
TR (1) TR200102395T2 (no)
WO (1) WO2000048988A1 (no)
YU (1) YU58601A (no)
ZA (1) ZA200106075B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6939855B2 (en) * 1997-07-31 2005-09-06 Elan Pharmaceuticals, Inc. Anti-inflammatory compositions and method
KR100720907B1 (ko) * 1999-08-13 2007-05-25 바이오겐 아이덱 엠에이 인코포레이티드 세포 유착 억제제
US6388084B1 (en) 1999-12-06 2002-05-14 Hoffmann-La Roche Inc. 4-pyridinyl-n-acyl-l-phenylalanines
US6380387B1 (en) 1999-12-06 2002-04-30 Hoffmann-La Roche Inc. 4-Pyrimidinyl-n-acyl-l phenylalanines
US7015323B2 (en) 2003-05-20 2006-03-21 Genentech, Inc. Thiocarbamate inhibitors of alpha-4 integrins
WO2006081986A1 (en) * 2005-02-07 2006-08-10 F.Hoffmann-La Roche Ag Bambuterol and integrin inhibitor combination
WO2006094640A2 (en) * 2005-03-04 2006-09-14 F.Hoffmann-La Roche Ag Roflumilast and integrin inhibitor combination and method of treatment
IL172896A0 (en) * 2005-12-29 2006-06-11 Yeda Res & Dev Cxcr4 inhibition
US8877815B2 (en) 2010-11-16 2014-11-04 Novartis Ag Substituted carbamoylcycloalkyl acetic acid derivatives as NEP

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE584914A (no) 1958-11-24
US3527793A (en) 1967-08-18 1970-09-08 Bristol Myers Co Phenylglycine derivatives
IT1190378B (it) 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
US5039805A (en) 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5463116A (en) 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
CA2191979A1 (en) 1994-06-20 1995-12-28 Muneo Takatani Condensed imidazole compounds, their production and use
US6306840B1 (en) 1995-01-23 2001-10-23 Biogen, Inc. Cell adhesion inhibitors
US5804595A (en) 1995-12-05 1998-09-08 Regents Of The University Of Minnesota Kappa opioid receptor agonists
PT891325E (pt) * 1996-03-29 2002-07-31 Searle & Co Derivados do acido fenilpropanoico para-substituido como antagonistas de integrina
DE69706407T2 (de) 1996-03-29 2002-05-29 Searle & Co META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN
ID19155A (id) * 1996-12-13 1998-06-18 Tanabe Seiyaku Co Turunan-turunan piridin, pembuatannya dan intermediet untuk pembuatannya
EP1001764A4 (en) * 1997-05-29 2005-08-24 Merck & Co Inc Heterocyclic amides as cell adhesion inhibitors
TR200000482T2 (tr) * 1997-08-22 2000-06-21 F. Hoffmann-La Roche Ag. N-Aroilfenilalanin türevleri.
PT1005446E (pt) * 1997-08-22 2004-06-30 Hoffmann La Roche Derivados de n-aroilfenilalanina
US6555562B1 (en) 1998-02-26 2003-04-29 Celltech R&D Limited Phenylalanine derivatives
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds

Also Published As

Publication number Publication date
HRP20010594A2 (en) 2002-08-31
CN1340043A (zh) 2002-03-13
TR200102395T2 (tr) 2001-12-21
EP1154987B1 (en) 2004-04-21
HRP20010594B1 (en) 2006-02-28
PL349463A1 (en) 2002-07-29
EP1154987A1 (en) 2001-11-21
ID30057A (id) 2001-11-01
ES2218116T3 (es) 2004-11-16
HUP0200343A2 (en) 2002-06-29
CZ20012984A3 (cs) 2002-02-13
ZA200106075B (en) 2002-10-24
CA2362833C (en) 2009-04-07
CN1213020C (zh) 2005-08-03
ATE264835T1 (de) 2004-05-15
HK1043589A1 (en) 2002-09-20
US6420600B1 (en) 2002-07-16
DE60010049D1 (de) 2004-05-27
NO20013946L (no) 2001-08-14
AU771938B2 (en) 2004-04-08
SI1154987T1 (en) 2004-08-31
YU58601A (sh) 2004-05-12
KR20010102260A (ko) 2001-11-15
JP2002537283A (ja) 2002-11-05
DK1154987T3 (da) 2004-08-09
IL144641A (en) 2006-09-05
CA2362833A1 (en) 2000-08-24
AU2548600A (en) 2000-09-04
NO20013946D0 (no) 2001-08-14
WO2000048988A1 (en) 2000-08-24
PT1154987E (pt) 2004-08-31
HUP0200343A3 (en) 2005-04-28
DE60010049T2 (de) 2005-03-31
RU2238265C2 (ru) 2004-10-20
KR100636458B1 (ko) 2006-10-18
MXPA01008178A (es) 2002-03-13
MA26772A1 (fr) 2004-12-20
BR0008368A (pt) 2001-11-06

Similar Documents

Publication Publication Date Title
HK1043589A1 (en) Phenylalaninol derivatives.
PL315030A1 (en) Method of bonding a flexible material with its associated substrate and product obtained thereby
PL367983A1 (en) Spiro compounds
NZ505089A (en) PPAR-gamma receptor activators, useful for the treatment of skin disorders
MY144184A (en) Disposable wearing article
ZA200203533B (en) 4-pyrimidinyl-N-acyl-L-phenylalanines.
EP1329459A3 (en) Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
ATE204471T1 (de) Pyrimidin- oder triazincarbonsäurederivate zur verwendung als arzneimittel
BR9609092A (pt) Prendedores de aba de fita para artigos absorventes descartáveis
HU9303009D0 (en) New 2-saccharinyl-methyl-aryl-carboxylat derivatives and pharmaceutical preparations containing said compounds
DE59100797D1 (de) Windel mit Dichtungsklappen.
NZ335318A (en) (o-acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines with anti-inflammatory activity
DE3880499T2 (de) Cyanhydrinderivate und deren verwendung in flüssigkristallmaterialien und vorrichtungen.
HUP0302440A2 (hu) Amino-kinolin származékok, eljárás előállításukra és ezeket hatóanyagként tartalmazó gyógyszerkészítmények

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed